• 1.

    Vivarelli M, et al.. Minimal change disease. Clin Am J Soc Nephrol 2017; 12:332345. doi: 10.2215/CJN.05000516

  • 2.

    Shalhoub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2:556560. doi: 10.1016/s0140-6736(74)91880-7

  • 3.

    Maas RJ, et al.. Permeability factors in idiopathic nephrotic syndrome: Historical perspectives and lessons for the future. Nephrol Dial Transplant 2014; 29:22072216. doi: 10.1093/ndt/gfu355

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Hogan J, Radhakrishnan J. The treatment of minimal change disease in adults. J Am Soc Nephrol 2013; 24:702711. doi: 10.1681/ASN.2012070734

  • 5.

    Tarshish P, et al.. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997; 8:769776. https://jasn.asnjournals.org/content/jnephrol/8/5/769.full.pdf?with-ds=yes

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Black DA, et al.. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 1970; 3:421426. doi: 10.1136/bmj.3.5720.421

  • 7.

    Nakayama M, et al.. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis 2002; 39:503512. doi: 10.1053/ajkd.2002.31400

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Waldman M, et al.. Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2007; 2:445453. doi: 10.2215/CJN.03531006

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Tse K-C, et al.. Idiopathic minimal change nephrotic syndrome in older adults: Steroid responsiveness and pattern of relapses. Nephrol Dial Transplant 2003; 18:13161320. doi: 10.1093/ndt/gfg134

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Chapter 5: Minimal-change disease in adults. Kidney Int Suppl 2012; 2:177180. doi:10.1038/kisup.2012.1

  • 11.

    Boumpas DT, et al.. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 1993; 119:11981208. doi: 10.7326/0003-4819-119-12-199312150-00007

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Huscher D, et al.. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009; 68:11191124. doi: 10.1136/ard.2008.092163

  • 13.

    Whitworth JA. Mechanisms of glucocorticoid-induced hypertension. Kidney Int 1987; 31:12131224. doi: 10.1038/ki.1987.131

  • 14.

    Gabriel SE, et al.. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115:787796. doi: 10.7326/0003-4819-115-10-787

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    van Staa TP, et al.. The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporosis Int 2002; 13:777787. doi: 10.1007/s001980200108

  • 16.

    Gurwitz JH, et al.. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 1994; 154:97101. doi: 10.1001/archinte.1994.00420010131015

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Dixon WG, et al.. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: A nested case-control analysis. Ann Rheum Dis 2012; 71:11281133. doi: 10.1136/annrheumdis-2011-200702

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Pepper RJ, et al.. A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 2019; 58:260268. doi: 10.1093/rheumatology/key288

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Fervenza FC, et al.. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med 2019; 381:3646. doi: 10.1056/NEJMoa1814427

  • 20.

    Medjeral-Thomas NR, et al.. Randomized, controlled trial of tacrolimus and prednisolone monotherapy for adults with de novo minimal change disease: A multicenter, randomized, controlled trial. Clin J Am Soc Nephrol 2020; 15:209218. doi: 10.2215/CJN.06180519

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Chin HJ, et al.. Comparison of the efficacy and safety of tacrolimus and low-dose corticosteroid with high-dose corticosteroid for minimal change nephrotic syndrome in adults. J Am Soc Nephrol 2021; 32:199210. doi: 10.1681/ASN.2019050546

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Ainley L, et al.. Treatment of concurrent minimal change disease and Epstein Barr virus-driven post-transplant lymphoproliferative disorder with rituximab following hematopoietic stem cell transplantation. Kidney Int Rep 2021; 6:224227. doi: 10.1016/j.ekir.2020.10.012

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Fenoglio R, et al.. Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. Oncotarget 2018; 9:2879928804. doi: 10.18632/oncotarget.25612.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Kim YC, et al.. Complete remission induced by tacrolimus and low-dose prednisolone in adult minimal change nephrotic syndrome: A pilot study. Kidney Res Clin Pract 2012; 31:112117. doi: 10.1016/j.krcp.2012.04.321

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Li X, et al.. Tacrolimus monotherapy after intravenous methylprednisolone in adults with minimal change nephrotic syndrome. J Am Soc Nephrol 2017; 28:12861295. doi: 10.1681/ASN.2016030342

    • PubMed
    • Search Google Scholar
    • Export Citation

Minimization in Minimal Change Disease: Maximal Change in Practice?

Dearbhla Kelly Dearbhla Kelly, MB, BCh, BAO, MSc, MRCPI, is a renal specialist registrar with Beaumont Hospital, Dublin, Ireland.

Search for other papers by Dearbhla Kelly in
Current site
Google Scholar
PubMed
Close
Restricted access
Save